ANTINEOPLASTICS TOXICITY
Clinical trials for ANTINEOPLASTICS TOXICITY explained in plain language.
Never miss a new study
Get alerted when new ANTINEOPLASTICS TOXICITY trials appear
Sign up with your email to follow new studies for ANTINEOPLASTICS TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart meds after cancer: can you finally stop?
Disease control Recruiting nowThis study looks at whether cancer survivors who had temporary heart damage from chemotherapy can safely stop taking heart failure medications once their heart function has recovered. About 335 adults who finished cancer treatment at least 6 months ago and are currently on heart …
Matched conditions: ANTINEOPLASTICS TOXICITY
Phase: PHASE4 • Sponsor: Dinesh Thavendiranathan • Aim: Disease control
Last updated May 26, 2026 10:25 UTC
-
New immunotherapy combo may let some bladder cancer patients keep their bladder
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab and relatlimab) before surgery can help some patients with stage II-IIIa bladder cancer avoid bladder removal. About 90 participants will receive either one or both drugs, and doctors will check if the cancer disa…
Matched conditions: ANTINEOPLASTICS TOXICITY
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 10:21 UTC